Cannabis Extracts: CO2 vs Ethanol vs BHO — A Clinician’s Guide

Why Extraction Method Matters in Medical Cannabis

• The extraction method determines which compounds are retained, which are removed, and what residual solvents may be present
• Medical-grade extracts require EU-GMP certified manufacturing with validated solvent removal processes
• Different extraction methods produce different cannabinoid:terpene ratios and product consistencies
• Understanding extraction is essential for interpreting CoAs and for explaining product differences to patients

Medical cannabis is available in many extract forms, from simple oil tinctures to highly concentrated distillates and full-spectrum preparations. The extraction method used to create these products fundamentally shapes their chemical composition, pharmacological profile, and safety characteristics. Prescribers who can explain the basics of extraction to patients — and interpret this information in product documentation — provide a higher standard of clinical guidance.

CO2 Extraction: The Gold Standard for Medical Products

• Supercritical CO2 extraction uses pressurised CO2 as a solvent — no toxic residuals remain in the final product
• Highly tunable: temperature and pressure adjustments allow selective extraction of specific cannabinoids or full-spectrum material
• Preserves terpene profile better than high-heat extraction methods when conducted at subcritical temperatures
• Most EU-GMP cannabis oil products use CO2 extraction due to its clean, controllable, and scalable nature

For prescribers recommending or interpreting cannabis oil products, EU-GMP CO2-extracted preparations represent the highest quality tier. The absence of solvent residue risk, combined with reproducible full-spectrum profiles, makes CO2-extracted oils the preferred choice for long-term medical use. Prescribers should check that the CoA includes residual solvent analysis even for CO2 products, as cross-contamination during processing can introduce solvents at earlier stages.

Ethanol Extraction: Efficient but Requires Rigorous Purification

• Ethanol is an effective polar solvent that extracts both cannabinoids and a broad range of plant constituents including chlorophyll
• Raw ethanol extract (RSO/FECO) contains waxes, lipids, and chlorophyll — typically dark green and strongly flavoured
• Post-extraction winterisation (cold filtration) and evaporation remove waxes and residual ethanol
• Residual ethanol must be below 5,000ppm in the final product per EU Pharmacopoeia standards

Ethanol-extracted products range from crude whole-plant extracts (Rick Simpson Oil/FECO style) to highly refined, winterised oils that closely resemble CO2 extracts in appearance and profile. The key clinical concern with ethanol extraction is residual solvent — products without validated solvent removal data should not be prescribed. The CoA must include ethanol residual analysis from the final batch, not just from an earlier production step.

BHO (Butane Hash Oil): Not Appropriate for Medical Prescribing

• BHO uses flammable butane gas as the extraction solvent — explosion risk during manufacture without industrial equipment
• Residual butane in inadequately purged products is a respiratory toxin with direct patient safety implications
• BHO products are predominantly associated with recreational “dabbing” — not with medical cannabis clinical practice
• EU-GMP certification explicitly excludes BHO as an acceptable manufacturing method for medicinal products

Prescribers encountering patient-sourced BHO products should advise clearly and without judgement that these are not medically appropriate preparations. The residual solvent risk, lack of quality documentation, and inconsistent cannabinoid content make BHO entirely unsuitable for therapeutic use within a medical framework. Redirecting patients toward licensed, quality-documented products is both clinically appropriate and legally important.